Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

7792 ARTÍCULOS , VIENDO DEL 2071 AL 2085

Expanding Horizons in Parkinson's Disease: Towards Integrated Care and Comprehensive Research

Rodríguez-Molinero A.

J Clin Med. 2025 Jan 9;14(2):385. doi: 10.3390/jcm14020385.

Neurogenic Orthostatic Hypotension in Parkinson Disease-A Narrative Review of Diagnosis and Management

Grosu C, Noea O, Maștaleru A, Ignat EB, Leon MM.

J Clin Med. 2025 Jan 19;14(2):630. doi: 10.3390/jcm14020630.

Biomechanics Parameters of Gait Analysis to Characterize Parkinson's Disease: A Scoping Review

Russo M, Amboni M, Pisani N, Volzone A, Calderone D, Barone P, Amato F, Ricciardi C, Romano M.

Sensors (Basel). 2025 Jan 9;25(2):338. doi: 10.3390/s25020338.

Mechanisms of Copper-Induced Autophagy and Links with Human Diseases

Fu Y, Zeng S, Wang Z, Huang H, Zhao X, Li M.

Pharmaceuticals (Basel). 2025 Jan 15;18(1):99. doi: 10.3390/ph18010099.

How to Manage an Individual Living with Parkinson's Disease Who Acutely Cannot Swallow

Teranaka M, Teranaka W, Jones HT.

Br J Hosp Med (Lond). 2025 Jan 24;86(1):1-10. doi: 10.12968/hmed.2024.0518. Epub 2025 Jan 17.

Are glucagon-like peptide-1 (GLP-1) receptor agonists useful in treating Parkinson's disease (PD)? Does the clinical trial with lixisenatide add anything?

Doggrell SA.

Expert Opin Investig Drugs. 2025 Jan-Feb;34(1-2):11-15. doi: 10.1080/13543784.2025.2459409. Epub 2025 Jan 29.

The double-edged sword role of natural Killer cells in Parkinson's disease

Daneshjou D, Nabavi SM, Shams P, Faranoush P, Salari M, Ebrahimi M.

Cell Immunol. 2025 Mar-Apr;409-410:104928. doi: 10.1016/j.cellimm.2025.104928. Epub 2025 Jan 23.

α-Synuclein distribution in olfactory mucosa and skin nerves in Parkinson disease associated with an EIF4G1 gene mutation

Braccia A, Elia AE, Devigili G, Lombardi R, Luppino A, Mazzetti S, Panteghini C, Colangelo I, Suerz M, Portaleone SM, Perilli AM, De Luca CMG, Ciullini A, Dellarole IL, Telese R, Garavaglia B, Moda F, Eleopra R.

J Neuropathol Exp Neurol. 2025 Apr 1;84(4):286-292. doi: 10.1093/jnen/nlaf001.

Unraveling the dual role of bilirubin in neurological Diseases: A Comprehensive exploration of its neuroprotective and neurotoxic effects

Kaur A, Rohit, Aran KR.

Brain Res. 2025 Mar 15;1851:149472. doi: 10.1016/j.brainres.2025.149472. Epub 2025 Jan 27.

Intestinal microbiota distribution and changes in different stages of Parkinson's disease: A meta-analysis, bioinformatics analysis and in vivo simulation

Jiang T, Wang Y, Fan W, Lu Y, Zhang G, Li J, Ma R, Liu M, Shi J.

Biosci Trends. 2025 Mar 6;19(1):87-101. doi: 10.5582/bst.2024.01352. Epub 2025 Jan 25.

Growth and differentiation factor 15: An emerging therapeutic target for brain diseases

Zhou Y, Dou L, Wang L, Chen J, Mao R, Zhu L, Liu D, Zheng K.

Biosci Trends. 2025 Mar 6;19(1):72-86. doi: 10.5582/bst.2024.01305. Epub 2025 Jan 25.

[Two cases of Perry disease (Perry syndrome) in the same family with normal (123)I-metaiodobenzylguanidine (MIBG) myocardial scintigraphy]

Take Y, Saigo R, Arata H, Sakiyama Y, Arimura K, Ohkatsu H.

Rinsho Shinkeigaku. 2025 Feb 21;65(2):115-119. doi: 10.5692/clinicalneurol.cn-001995. Epub 2025 Jan 24.

Sleep and circadian dysfunction in Parkinson disease: New perspective and opportunities for treatment

Shen Y, Liu CF.

Handb Clin Neurol. 2025;206:193-209. doi: 10.1016/B978-0-323-90918-1.00002-2.

Irregular sleep-wake rhythm disorder: From the pathophysiologic perspective to the treatment

Videnovic A, Cai A.

Handb Clin Neurol. 2025;206:71-87. doi: 10.1016/B978-0-323-90918-1.00006-X.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias